---
figid: PMC6912965__JAH3-8-e014201-g001
figtitle: Underlying mechanisms of Tregs in PAH
organisms:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- Coxsackievirus B3
organisms_ner:
- Rattus norvegicus
- Mus musculus
- Homo sapiens
- Danio rerio
pmcid: PMC6912965
filename: JAH3-8-e014201-g001.jpg
figlink: /pmc/articles/PMC6912965/figure/jah34646-fig-0001/
number: F1
caption: Underlying mechanisms of Tregs in PAH. Tregs repair injured PAECs and endothelium
  integrity by secreting interleukin‐10 and upregulating BMPR2 expression. Tregs inhibit
  excessive PASMC proliferation and apoptosis resistance by suppressing the Akt and
  ERK pathway, reducing cyclin D1 and CDK expression, and restraining the RhoA/ROCK
  pathway. Tregs regulate abnormal fibroblast proliferation and activation by suppressing
  TGF‐β and FGF‐9 production, inhibiting the CXCL12–CXCR4 axis, suppressing leukotriene
  B4 production, and directly secreting interleukin‐10 and interferon‐γ. BMPR2 indicates
  bone morphogenetic protein receptor type 2; CDK, cyclin‐dependent kinase; CXCL12–CXCR4,
  chemokine (C‐X‐C motif) ligand 12—CXC receptor 4; ERK, extracellular signal‐regulated
  kinase; FGF‐9, fibroblast growth factor‐9; LTB4, leukotriene B4; PAEC, pulmonary
  arterial endothelial cell; PASMC, pulmonary arterial smooth muscle cell; TGF‐β,
  transforming growth factor‐β.
papertitle: The Role of Regulatory T Cells in Pulmonary Arterial Hypertension.
reftext: Haihua Qiu, et al. J Am Heart Assoc. 2019 Dec 3;8(23):e014201.
year: '2019'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.8973146
figid_alias: PMC6912965__F1
figtype: Figure
redirect_from: /figures/PMC6912965__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6912965__JAH3-8-e014201-g001.html
  '@type': Dataset
  description: Underlying mechanisms of Tregs in PAH. Tregs repair injured PAECs and
    endothelium integrity by secreting interleukin‐10 and upregulating BMPR2 expression.
    Tregs inhibit excessive PASMC proliferation and apoptosis resistance by suppressing
    the Akt and ERK pathway, reducing cyclin D1 and CDK expression, and restraining
    the RhoA/ROCK pathway. Tregs regulate abnormal fibroblast proliferation and activation
    by suppressing TGF‐β and FGF‐9 production, inhibiting the CXCL12–CXCR4 axis, suppressing
    leukotriene B4 production, and directly secreting interleukin‐10 and interferon‐γ.
    BMPR2 indicates bone morphogenetic protein receptor type 2; CDK, cyclin‐dependent
    kinase; CXCL12–CXCR4, chemokine (C‐X‐C motif) ligand 12—CXC receptor 4; ERK, extracellular
    signal‐regulated kinase; FGF‐9, fibroblast growth factor‐9; LTB4, leukotriene
    B4; PAEC, pulmonary arterial endothelial cell; PASMC, pulmonary arterial smooth
    muscle cell; TGF‐β, transforming growth factor‐β.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Il10
  - Akt1
  - Ephb1
  - Ccnd1
  - Bmpr2
  - Rhoa
  - Fgf9
  - Tgfb1
  - Ephb2
  - Mapk1
  - Ltbp1
  - IL10
  - AKT1
  - AKT2
  - AKT3
  - EPHB2
  - MAPK1
  - MAPK3
  - CDKL1
  - CDKL2
  - CDKL3
  - CDKL4
  - CDKL5
  - CDK3
  - CDK4
  - CDK5
  - CDK6
  - CDK7
  - CDK8
  - CDK9
  - CDK10
  - CDK11A
  - CDK11B
  - CDK12
  - CDK13
  - CDK14
  - CDK15
  - CDK16
  - CDK17
  - CDK18
  - CDK19
  - CDK20
  - CDK1
  - CDK2
  - CCND1
  - BMPR2
  - RHOA
  - ROCK1
  - ROCK2
  - FGF9
  - TGFB1
  - TGFB2
  - TGFB3
  - il10
  - ccnd1
  - rhoaa
  - rhoab
  - fgf9
---
